Growth Metrics

Bluejay Diagnostics (BJDX) Times Interest Earned (2024 - 2025)

Bluejay Diagnostics recorded quarterly Times Interest Earned of -$7816.8 in Q4 2025, up 3.31% quarter-over-quarter from -$8084.7 in Q3 2025, and down 283.83% year-over-year from $4252.3 in Q4 2024.

Bluejay Diagnostics' Times Interest Earned history runs 2 years deep, the most recent figure standing at -$7816.8 for Q4 2025.

  • In Q4 2025, Times Interest Earned fell 283.83% year-over-year to -$7816.8; the TTM figure through Mar 2026 stood at -$11499.0 (down 141730.8% YoY), while the FY2025 annual figure was -$8287.2, down 95032.13% from the prior year.
  • Times Interest Earned came in at -$7816.8 for Q4 2025 at Bluejay Diagnostics, up from -$8084.7 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$3.03 in Q2 2024 to a low of -$8943.1 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 7.73
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 6.32
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 8.09
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 12.23
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -2.90
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 5.36
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 20.98
10 Bluejay Diagnostics 572,394.44 -3.11 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -7,816.83
Sep 30, 2025 -8,084.74
Jun 30, 2025 -8,943.07
Dec 31, 2024 -2,036.55
Sep 30, 2024 -7.14
Jun 30, 2024 -3.03